Emtricitabine Cyclic-I impurity

Emtricitabine Cyclic-I impurity is a cyclic hemiacetal derivative formed via intramolecular cyclization of the parent nucleoside, featuring a 1,3-dioxolan ring fused to the cyano-substituted benzene moiety. The compound retains the 5’-hydroxyl group but exhibits a ketal linkage at the 2’-position, distinguishing it from linear degradation products. This impurity arises during API synthesis under acidic conditions and serves as a critical HPLC reference standard for quantifying process-related cyclic byproducts in Emtricitabine formulations.